Urina Tech
Urine-based diagnostics for early disease detection and monitoring
Company Overview
Snapshot
Founded in August 2025, Urina Tech operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its diagnostic solutions.
Business overview
Urina Tech specializes in developing non-invasive, urine-based diagnostic solutions for the early detection and continuous monitoring of chronic and acute diseases. The company combines advanced biochemical assays with data analytics, leveraging AI to deliver accurate, user-friendly tests. Its technology aims to improve diagnostic sensitivity, reduce patient burden, and lower overall testing costs for healthcare providers and payers, operating within the Health Tech & Life Sciences sector, specifically in Medical Devices and Diagnostics Devices.
Company Intelligence Q&A
- What is Urina Tech's primary focus?
- Urina Tech focuses on developing non-invasive, urine-based diagnostic solutions for the early detection and continuous monitoring of chronic and acute diseases.
- When was Urina Tech founded?
- Urina Tech was founded in August 2025.
- What technology does Urina Tech utilize?
- Urina Tech combines advanced biochemical assays with data analytics, leveraging AI to deliver accurate and easy-to-use diagnostic tests.
- In which sector does Urina Tech primarily operate?
- Urina Tech operates primarily in the Health Tech & Life Sciences sector, specifically within Medical Devices and Diagnostics Devices.
- What is the current product stage of Urina Tech?
- Urina Tech's products are currently in the Research and Development (R&D) stage, indicating that the company is actively working on developing and refining its diagnostic solutions.